Brian Baker

Company: Regeneron

Job title: Senior Director, Regulatory Affairs (CDx)

Seminars:

Clinical Interchangeability of PD-L1 IHC Assays for the Treatment of 1L NSCLC with Cemiplimab 10:30 am

• Bridging study demonstrating high level of concordance and equivalent association of clinical efficacy with Cemiplimab in the PD-L1 >50% population • Regulatory strategy supporting clinical validation/registration of a follow-on PD-L1 CDxRead more

day: Day 1 blue